Showing results (111-120 of 141) with videos related to
Sort By:
Pageof 15
Journal of Pharmaceutical Sciences|February 9, 2002
Long-acting forms of Sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury modelR Blake Pepinsky, Renee I Shapiro, Shaoshan Wang, et al.Journal of Medical Virology|December 26, 2022
Mpox diagnostics: Review of current and emerging technologiesChuan Kok Lim, Jason Roberts, Michael Moso, et al.Journal of Geriatric Cardiology : JGC|December 15, 2023
Flattening the biological age curve by improving metabolic health: to taurine or not to taurine, that' s the questionKwok M Ho, Anna Lee, William Wu, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2009
Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic painLisa C Loram, Jacqueline A Harrison, Evan M Sloane, et al.The Journal of Pain|May 4, 2010
Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial primingLeah E Hains, Lisa C Loram, Julie L Weiseler, et al.International Journal of Antimicrobial Agents|November 6, 2025
An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoringDaniel Fresán, Luisa Sorlí, Jaume Barceló-Vidal, et al.Intensive Care Medicine|March 20, 2019
Obesity in the critically ill: a narrative reviewMiet Schetz, Audrey De Jong, Adam M Deane, et al.BMJ Surgery, Interventions, & Health Technologies|November 17, 2022
Development of a core minimum data set to advance real-world evidence generation for uterine fibroids treatment technologiesCourtney E Baird, Evan Myers, Vanessa Jacoby, et al.Trials|July 16, 2020
The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trialJustin T Denholm, Joshua Davis, David Paterson, et al.International Immunology|October 7, 2004
The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challengeJanine L Ferrant, Christopher D Benjamin, Anne H Cutler, et al.Pageof 15